Self-managed medication abortion trajectories: results from a prospective observational study in Argentina, Nigeria and Southeast Asia.

Reproductive Health abortion abortion, induced epidemiology surveys and questionnaires

Journal

BMJ sexual & reproductive health
ISSN: 2515-2009
Titre abrégé: BMJ Sex Reprod Health
Pays: England
ID NLM: 101715577

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 12 07 2023
accepted: 11 10 2023
medline: 1 11 2023
pubmed: 1 11 2023
entrez: 31 10 2023
Statut: aheadofprint

Résumé

Time is a crucial factor in abortion-seeking because options for care change with pregnancy duration, and most people prefer to access abortion care early in pregnancy. We aimed to collect data on the timing of steps in accompanied self-managed abortion-seeking experiences in legally restrictive settings. In this prospective, observational, cohort study we recruited callers from three abortion accompaniment groups in Argentina, Nigeria and a country in Southeast Asia. Participants completed a baseline survey before starting a self-managed medication abortion (SMA) and two follow-up surveys (approximately 1 and 3 weeks after taking medication). Primary outcomes of interest included: (1) time from abortion decision to contacting the hotline, (2) time from contacting the hotline to obtaining pills and (3) time from obtaining pills to taking the first dose. We explored relationships between participant characteristics and each of these outcomes and evaluated differences in overall abortion time using survival analyses. Between July 31, 2019 and October 01, 2020 we enrolled 1352 eligible callers; 1148 provided data for this analysis. After deciding to have an abortion, participants took 12.2 days on average (95% CI: 11.6, 12.9) to start medications for abortion. On average, participants at later pregnancy durations progressed through the SMA process more quickly (<4 weeks: 20.9 days, 4 weeks: 11 days, 5-6 weeks: 10.1 days, 7-9 weeks, 10.4 days, 10+ weeks: 9.1 days; p<0.001). Overall, participants accessed accompaniment group support and started abortion regimens quickly and at relatively early pregnancy durations. SMA with accompaniment provided a time-efficient route for obtaining abortions.

Identifiants

pubmed: 37907254
pii: bmjsrh-2023-201979
doi: 10.1136/bmjsrh-2023-201979
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Elizabeth A Pleasants (EA)

School of Public Health, University of California Berkeley, Berkeley, California, USA.

Ruvani T Jayaweera (RT)

Ibis Reproductive Health, Oakland, California, USA.

Ijeoma Egwuatu (I)

Generation Initiative for Women and Youth, Lagos, Nigeria.

Sybil Nmezi (S)

Generation Initiative for Women and Youth, Lagos, Nigeria.

Ika Ayu Kristianingrum (IA)

Samsara, Java, Indonesia.

Ruth Zurbriggen (R)

La Revuelta Colectiva Feminista, Neuquén, Argentina.

Belén Grosso (B)

La Revuelta Colectiva Feminista, Neuquén, Argentina.

Chiara Bercu (C)

Ibis Reproductive Health, Oakland, California, USA.

Relebohile Motana (R)

Ibis Reproductive Health, Johannesburg, Gauteng, South Africa.

Caitlin Gerdts (C)

Ibis Reproductive Health, Oakland, California, USA.

Heidi Moseson (H)

Ibis Reproductive Health, Oakland, California, USA hmoseson@ibisreproductivehealth.org.

Classifications MeSH